At Immunoshop we continuously strive to align our products,
processes and services to ever-changing customer needs, technologies
and market situation so as to deliver best value to our customers,
partners and employees ..More
News
INSTI HIV-1/HIV-2 Antibody Rapid Test
The benefits of the Test are as below:
1)The test uses specimen of convenience ie. EDTA whole blood or finger stick blood. Also can be done with plasma or serum.
2)Fastest rapid kit in the world-results within 60 seconds.
3)It is a flow through technology and not lateral flow.
4)Test has built in procedural control and true biological IgG control. This IgG control allows a safeguard against errors in the field and performance inconsistencies.
5)Highly accurate. It utilizes recombinant transmembrane proteins from HIV-1 and HIV-2. This overcomes sensitivity and specificity problems associated with a test that based on viral lysates or a combination of core antigen and other viral proteins. Detects antibodies to all subtypes of HIV including the known circulating recombinant forms and group O.
6)All materials in kit/no equipment needed
7)Stable at Room Temperature and high temperatures, giving it portability without refrigeration.
8)Simple and easy to use
9)Easily read visual end-point
10)INSTI enhances the efficiency of Voluntary Counseling & Test Centers as preliminary results as known immediately during the patients visit as this saves a lot of time and manpower and further increases the chances of tracing HIV positive patients and as a result timely directing them to proper care and support.
11)Accuracy levels of 99.96% in proven clinical studies and evaluations around the world.The INSTI™ kit is extremely accurate. It consistently scores over 99.96%, in many tests run by independent assessment laboratories, as well as in the multi-center Canadian clinical trials. INSTI™ is the only Health Canada approved kit for point of care use on the market to date.
Some of the Approvals for INSTI HIV Antibody Test:
•USAID Approval with PEPFAR (African and Caribbean countries).
•CE approval for the European Union.
•Extensively tested on BBI and sero conversion panels.
•Health Canada FDA approval (Only product with a class 4 designation for HIV testing at Point of Care, clinical trial was over 2 years and involved 16,500 samples.
